| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 2.38e-04 | 59 | 8 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 7.01e-04 | 1180 | 8 | 4 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 9.80e-04 | 1289 | 8 | 4 | GO:0005215 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.67e-03 | 293 | 8 | 2 | GO:0008514 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 5.78e-03 | 296 | 8 | 2 | GO:0015291 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.45e-02 | 477 | 8 | 2 | GO:0022804 | |
| Domain | MFS_dom | 1.97e-05 | 134 | 8 | 3 | IPR020846 | |
| Domain | MFS | 4.62e-04 | 77 | 8 | 2 | IPR011701 | |
| Domain | MFS_1 | 4.62e-04 | 77 | 8 | 2 | PF07690 | |
| Domain | MFS | 9.07e-04 | 108 | 8 | 2 | PS50850 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.74e-03 | 238 | 5 | 2 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.00e-03 | 249 | 5 | 2 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.11e-02 | 681 | 5 | 2 | MM14985 | |
| Interaction | IPO13 interactions | 5.59e-06 | 95 | 8 | 3 | int:IPO13 | |
| Interaction | ZMAT4 interactions | 5.96e-05 | 30 | 8 | 2 | int:ZMAT4 | |
| Interaction | DDX20 interactions | 7.28e-05 | 224 | 8 | 3 | int:DDX20 | |
| Interaction | DUSP15 interactions | 8.15e-05 | 35 | 8 | 2 | int:DUSP15 | |
| Interaction | AMFR interactions | 8.61e-05 | 237 | 8 | 3 | int:AMFR | |
| Interaction | GEMIN4 interactions | 1.32e-04 | 274 | 8 | 3 | int:GEMIN4 | |
| Interaction | MMS19 interactions | 1.92e-04 | 311 | 8 | 3 | int:MMS19 | |
| Interaction | AGPAT2 interactions | 3.01e-04 | 67 | 8 | 2 | int:AGPAT2 | |
| Interaction | SEC22B interactions | 3.44e-04 | 379 | 8 | 3 | int:SEC22B | |
| Interaction | TUBB8 interactions | 3.66e-04 | 387 | 8 | 3 | int:TUBB8 | |
| Interaction | STARD3 interactions | 3.67e-04 | 74 | 8 | 2 | int:STARD3 | |
| Interaction | SLC35E1 interactions | 4.08e-04 | 78 | 8 | 2 | int:SLC35E1 | |
| Interaction | CHP1 interactions | 4.62e-04 | 83 | 8 | 2 | int:CHP1 | |
| Interaction | EI24 interactions | 4.96e-04 | 86 | 8 | 2 | int:EI24 | |
| Interaction | VPS4A interactions | 5.55e-04 | 91 | 8 | 2 | int:VPS4A | |
| Interaction | FASTKD1 interactions | 6.04e-04 | 95 | 8 | 2 | int:FASTKD1 | |
| Interaction | CAND2 interactions | 6.04e-04 | 95 | 8 | 2 | int:CAND2 | |
| Interaction | POM121C interactions | 6.69e-04 | 100 | 8 | 2 | int:POM121C | |
| Interaction | TTI1 interactions | 6.83e-04 | 101 | 8 | 2 | int:TTI1 | |
| Interaction | ATL2 interactions | 7.24e-04 | 104 | 8 | 2 | int:ATL2 | |
| Interaction | RARS2 interactions | 7.38e-04 | 105 | 8 | 2 | int:RARS2 | |
| Interaction | COG4 interactions | 7.80e-04 | 108 | 8 | 2 | int:COG4 | |
| Interaction | COQ8B interactions | 8.09e-04 | 110 | 8 | 2 | int:COQ8B | |
| Interaction | SLC39A14 interactions | 8.54e-04 | 113 | 8 | 2 | int:SLC39A14 | |
| Interaction | THADA interactions | 8.99e-04 | 116 | 8 | 2 | int:THADA | |
| Interaction | DERL2 interactions | 1.03e-03 | 124 | 8 | 2 | int:DERL2 | |
| Interaction | VKORC1 interactions | 1.09e-03 | 128 | 8 | 2 | int:VKORC1 | |
| Interaction | NOM1 interactions | 1.13e-03 | 130 | 8 | 2 | int:NOM1 | |
| Interaction | TAP1 interactions | 1.18e-03 | 133 | 8 | 2 | int:TAP1 | |
| Interaction | TELO2 interactions | 1.21e-03 | 135 | 8 | 2 | int:TELO2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.53e-03 | 345 | 8 | 2 | chr11q12 | |
| GeneFamily | Solute carriers | 1.97e-04 | 395 | 6 | 3 | 752 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.90e-06 | 187 | 8 | 3 | 29b2e2be26a9d72b154760e47acf61cfe2f45fa7 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.96e-06 | 188 | 8 | 3 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.09e-06 | 190 | 8 | 3 | 7ba2be2630183df86de21689289a8620a4cd507e | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.42e-06 | 195 | 8 | 3 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.77e-06 | 200 | 8 | 3 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.01e-04 | 149 | 8 | 2 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.34e-04 | 157 | 8 | 2 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.51e-04 | 161 | 8 | 2 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-04 | 164 | 8 | 2 | 1592a5becad7e0f3f990f0d7581d75fcfc7da023 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-04 | 166 | 8 | 2 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.78e-04 | 167 | 8 | 2 | 1e144c03409df94ccd39760842590e8ea7487e29 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 172 | 8 | 2 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 172 | 8 | 2 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-04 | 173 | 8 | 2 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-04 | 173 | 8 | 2 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-04 | 173 | 8 | 2 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-04 | 174 | 8 | 2 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-04 | 177 | 8 | 2 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.29e-04 | 178 | 8 | 2 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.29e-04 | 178 | 8 | 2 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.34e-04 | 179 | 8 | 2 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.34e-04 | 179 | 8 | 2 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.44e-04 | 181 | 8 | 2 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-04 | 182 | 8 | 2 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.58e-04 | 184 | 8 | 2 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.68e-04 | 186 | 8 | 2 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.68e-04 | 186 | 8 | 2 | b9e0a819cd0b250f077b26eba99e6986d68d647b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-04 | 187 | 8 | 2 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.73e-04 | 187 | 8 | 2 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Club-club-14|World / Class top | 4.73e-04 | 187 | 8 | 2 | 4584de577d3736c89187e522497498e58d381c46 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.78e-04 | 188 | 8 | 2 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.83e-04 | 189 | 8 | 2 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-04 | 190 | 8 | 2 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-04 | 190 | 8 | 2 | d0297d678498e346e56cf95fe9e3db7d3ad3b837 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.89e-04 | 190 | 8 | 2 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-04 | 190 | 8 | 2 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-04 | 191 | 8 | 2 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-04 | 193 | 8 | 2 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-04 | 193 | 8 | 2 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.09e-04 | 194 | 8 | 2 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 194 | 8 | 2 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.09e-04 | 194 | 8 | 2 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-04 | 195 | 8 | 2 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-04 | 195 | 8 | 2 | 3f517c6fc372bdcaf45b3af373414f13cbebd4ba | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 195 | 8 | 2 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 195 | 8 | 2 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 195 | 8 | 2 | d6e2a5a15bea16de5f7ff09318c67d46ea923203 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-04 | 195 | 8 | 2 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.20e-04 | 196 | 8 | 2 | e16f0831f1f677b28e4a8014f0aede7e713d4f04 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.20e-04 | 196 | 8 | 2 | 71e88d9ca28168732bd91f2d4f8f53bb4187963a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 5.41e-04 | 200 | 8 | 2 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-04 | 200 | 8 | 2 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.41e-04 | 200 | 8 | 2 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; HL60; HT_HG-U133A | 1.71e-03 | 181 | 8 | 2 | 2378_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 1664_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 1667_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 5579_UP | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 3387_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 2771_UP | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 2722_DN | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 6835_UP | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 7352_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 2168_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 6259_UP | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 3269_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 6247_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 4373_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 1536_UP | |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 6504_UP | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2844_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 6845_UP | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3359_DN | |
| Drug | Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2781_UP | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7356_DN | |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2762_UP | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2818_UP | |
| Drug | estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5955_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5975_UP | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3225_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; HL60; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2553_DN | |
| Drug | Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3533_DN | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4767_DN | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2792_UP | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4977_DN | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3459_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3453_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5202_UP | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3529_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6867_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2176_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3042_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6261_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5106_DN | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6829_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5246_DN | |
| Disease | Schizophrenia | 2.22e-02 | 883 | 8 | 2 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YMPVTIMTILYWRIY | 241 | P20309 | |
| SLETVWQVYYPMMRP | 1826 | Q9UPY3 | |
| YMVPWPLVLMIFNIS | 96 | Q9Y342 | |
| YAFWIMALINLPVPM | 221 | Q8N468 | |
| MMILSIYSRPLPWII | 486 | Q6T423 | |
| ILPVMVTLVPYWMVY | 316 | Q8IY34 | |
| ILTMGYWPTYVPMEV | 681 | Q13620 | |
| VIGVTLPIMWFYLLM | 231 | Q969S0 |